RightFit
RecruitingNot applicable

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

A Prospective, Multicenter Study of the Glaukos® iStent Infinite Trabecular Micro-Bypass System Model iS3 in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
35 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests the Glaukos iStent infinite device in adults age 35 or older with mild to moderate primary open-angle glaucoma, a disease that damages the eye nerve. It is for people whose usual medicines and surgery have not failed to treat their glaucoma.

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have primary open-angle glaucoma.
  • Have your natural eye lens or an artificial lens from surgery.
  • Be age 35 or older.

Who can't join

  • Have glaucoma caused by an eye injury, eye inflammation, or abnormal new blood vessels.
  • Have angle-closure glaucoma, where the eye’s drainage opening is blocked.
  • Have glaucoma linked to blood vessel disorders.
  • Have active inflammation or swelling in the cornea, the clear front layer of the eye.
  • Have a disorder of the retina, the light-sensing layer at the back of the eye, that is not linked to glaucoma.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Diagnosis of primary open-angle glaucoma * Phakic or pseudophakic * Age 35 years or older Exclusion Criteria: * Traumatic, uveitic, neovascular, angle-closure glaucoma or * glaucoma associated with vascular disorders * Active corneal inflammation or edema * Retinal disorders not associated with glaucoma

Study sites (1)

OH